Cite
HARVARD Citation
Estepp, J. et al. (2022). Safety and efficacy of voxelotor in pediatric patients with sickle cell disease aged 4 to 11 years. Pediatric blood & cancer. 69 (8), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Estepp, J. et al. (2022). Safety and efficacy of voxelotor in pediatric patients with sickle cell disease aged 4 to 11 years. Pediatric blood & cancer. 69 (8), p. n/a. [Online].